You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Litigation Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket	⤷ Try a Trial	Date Filed	2018-12-06
Court	District Court, D. Delaware	Date Terminated	2021-09-08
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	6,956,041; 7,091,208; 7,265,221; 7,301,023; 9,937,181
Link to Docket	External link to docket

Small Molecule Drugs cited in Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .

Biologic Drugs cited in Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.

The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .

Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-02-20			Regarding Infringement of Claim 1 of U.S. Patent No. 9,937,181. Signed by Judge Leonard P. Stark on 2/21… 8 September 2021 1:18-cv-01940 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-12-06	1		Xeljanz XR that are not at issue: U.S. Patent Nos. 6,956,041 (expiring December 8, 2020); 7,091,208 (… infringement of United States Patent No. 9,937,181 (the “’181 patent”). 2. This action …181 patent as March 14, 2034. 18. The Orange Book also lists four additional patents for …). The ’181 Patent 19. On April 10, 2018, the USPTO issued the ’181 patent, titled “Tofacitinib…Forms.” The ’181 patent is duly and legally assigned to Pfizer. A copy of the ’181 patent is attached hereto	External link to document
2021-01-18	102	Notice of Service	Fleckenstein, Pharm.D., Regarding Validity of U.S. Patent No. 9,937,181; and (3) Responsive Expert Report of Leah…Appel, Ph.D., Regarding Validity of U.S. Patent No. 9,937,181 filed by C.P. Pharmaceuticals International… 8 September 2021 1:18-cv-01940 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-12-06	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,937,181 B2. (ceg) (Entered:… 8 September 2021 1:18-cv-01940 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-02-13	51	Stipulation-General (See Motion List for Stipulation to Extend Time)	Regarding Infringement of Claim 1 of U.S. Patent No. 9,937,181 by C.P. Pharmaceuticals International C.… 8 September 2021 1:18-cv-01940 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.